Vanguard Personalized Indexing Management’s Avidity Biosciences RNAM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,695	Closed	-$771K	–	2227
2025 Q4	$771K	Buy	10,695 +901	+9%	+$58.2K	0.01%	1039
2025 Q3	$427K	Buy	9,794 +635	+7%	+$25.7K	﹤0.01%	1316
2025 Q2	$260K	Buy	9,159 +1,786	+24%	+$53.2K	﹤0.01%	1507
2025 Q1	$218K	Buy	+7,373	New	+$230K	﹤0.01%	1484
2024 Q4	–	Sell	-5,247	Closed	-$241K	–	1859
2024 Q3	$241K	Buy	+5,247	New	+$228K	﹤0.01%	1447

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Vanguard Personalized Indexing Management's RNAM Position: Q1 2026 in Review

Vanguard Personalized Indexing Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 10,695 shares — an estimated $771K sold.

Vanguard Personalized Indexing Management first reported a position in RNAM in Q3 2024 and held it in 5 quarters. The position peaked at $771K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Vanguard Personalized Indexing Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 10,695 Avidity Biosciences shares in Q1 2026, an estimated $771K.
Vanguard Personalized Indexing Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 5 quarters.
Vanguard Personalized Indexing Management's Avidity Biosciences position peaked at $771K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.